Most Popular Stories
- Asif Ahmad - Disruptive Forces in Health IT
- Blumenthal: Federal program will ease IT worker shortage
- Verizon opens HIE services to imaging, test results, small providers
- 'Virtual white board' helps to cut hospital length of stay
- Ryan Howard - Disruptive Forces in Health IT
- Insurers increased denials by 49 percent because of pre-existing conditions
Featured Jobs
Events
- Executive Breakfast: Telemedicine Success: Opportunities for Seamless Care, Reduced Costs, and Broader Access
Nov 9 - IHI National Forum on Quality Improvement in Health Care
Dec 5-8, 2010 — Orlando, FL - Healthcare Reform: Overcoming Hurdles
Nov 8-9, 2010 — Washington, DC - AMIA Joint Summits on Translational Science
March 7-11, 2011 — San Francisco, CA
Paid Research Reports
-
Electronic health records: getting it right first time
-
Cloud Computing Adoption In The APAC Life Sciences Industry
-
Stakeholder Opinions: Ophthalmology - Leading brands under threat
-
Genomics, Proteomics and Metabolomics in Diagnostics: Market landscape, innovative technologies and future outlook
-
Healthcare Regulatory Update: The United Arab Emirates
-
Point of Care Testing: Evaluating the return to evidence based medicine, novel technologies and the competitive landscape
Free Newsletter
FierceHealthPayer provides the latest news about the fast-changing and heavily regulated area of healthcare reimbursement. Join thousands of healthcare plan executives who get FierceHealthPayer via weekly email. Sign up today!
Top Tags
We never sell or give away your contact information. Our reader's trust comes first.
SPOTLIGHT: Late-stage cancer patients are over-tested
Doing screening tests on patients whose life expectancy is extremely limited because of cancer is not cost-effective, according to a new study published in the Journal of the American Medical Association. The study examined the issue of overtesting in late-stage cancer and raises new questions about overdiagnosis and overtreatment in the healthcare system. Too many tests can raise anxiety in patients and lead to unneeded follow-up tests and treatments that can have serious complications, the study found. Article
Related Stories
Comments
Post new comment
Home | Subscribe | Advertise | Mobile Edition | RSS | Privacy | Site MapTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceHealthPayer | FiercePracticeManagement | FierceEMR | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceMedicalDevices | FierceDrugDelivery | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe | FierceCable© 2010 FierceMarkets. All rights reserved. |